HPCSA Pharmacology Research Topics for Registrars – South Africa

Comprehensive list of pharmacology research topics designed specifically for HPCSA registrars in South Africa. These topics address common and high-impact pharmacology challenges including antimicrobial use, adverse drug reactions, pharmacovigilance, antiretroviral therapy, tuberculosis treatment, drug interactions, rational prescribing, medication adherence, pharmacoeconomics, therapeutic drug monitoring, analgesic use, chronic disease medicines, and medication safety across district hospitals, regional hospitals, tertiary hospitals, primary healthcare clinics, pharmacy departments, pharmacovigilance units, and academic centres.

Why These Pharmacology Research Topics Work for HPCSA Registrars

HPCSA pharmacology registrar research must be feasible within the 4-year training programme while addressing clinically relevant questions in South African prescribing, medication safety, and health system practice. Each topic below has been selected for:

• Clinical relevance: Addresses real medication-use problems commonly encountered in South African hospitals, clinics, pharmacies, and public health programmes
• Feasibility: Achievable using prescription audits, pharmacy records, laboratory data, adverse drug reaction reports, patient records, antimicrobial stewardship data, and pharmacovigilance databases
• Ethical approval: Clear pathways for IRB submission, retrospective record review, anonymised prescription audits, informed consent where required, and supervisor approval
• Publication potential: Suitable for South African Medical Journal, Southern African Journal of Infectious Diseases, BMC Pharmacology and Toxicology, or international clinical pharmacology journals
• South African disease burden: Focuses on HIV, tuberculosis, antimicrobial resistance, non-communicable diseases, medicine access, adverse drug reactions, prescribing quality, and resource-appropriate pharmacotherapy

Rational Prescribing, Medication Safety and Pharmacovigilance Research Topics

Topic 1: Prescription Audit of Antibiotic Use in a District Hospital

Research Question: What are the prescribing patterns of antibiotics in a district hospital and how often do they comply with standard treatment guidelines?

Study Design: Retrospective prescription audit

Setting: District hospital outpatient department, emergency department, or inpatient wards

Why This Works: Antibiotic misuse contributes to antimicrobial resistance, prescriptions and case records are usually available, and the study can assess indication, choice of antibiotic, dose, duration, route, culture testing, guideline compliance, and opportunities for antimicrobial stewardship.

Topic 2: Adverse Drug Reaction Reporting Patterns in a Tertiary Hospital

Research Question: What are the common adverse drug reactions reported in a tertiary hospital and what factors are associated with serious reactions?

Study Design: Retrospective pharmacovigilance record review

Setting: Tertiary hospital pharmacovigilance unit or pharmacy department

Why This Works: Pharmacovigilance is central to safe medicine use, ADR records can be reviewed, and variables such as suspected drug, reaction type, severity, preventability, causality assessment, affected system, age, comorbidities, and outcome can be analysed.

Topic 3: Knowledge and Practice of Adverse Drug Reaction Reporting Among Healthcare Workers

Research Question: What is the knowledge, attitude, and practice of adverse drug reaction reporting among doctors, nurses, and pharmacists?

Study Design: Cross-sectional questionnaire-based study

Setting: District, regional, or tertiary hospital

Why This Works: Under-reporting of ADRs is common, validated questionnaires can be used, and the study can identify training gaps, barriers to reporting, awareness of reporting systems, and differences between professional groups.

Topic 4: Medication Errors in Inpatient Wards

Research Question: What are the types, frequency, and preventability of medication errors among patients admitted to inpatient wards?

Study Design: Retrospective audit or prospective observational study

Setting: Medical, surgical, paediatric, or obstetric inpatient wards

Why This Works: Medication errors are preventable causes of harm, prescription charts and nursing administration records can be reviewed, and errors such as wrong dose, wrong frequency, omission, duplication, allergy oversight, and drug interaction can be assessed.

Topic 5: Polypharmacy and Potentially Inappropriate Medicines in Elderly Patients

Research Question: What is the prevalence of polypharmacy and potentially inappropriate medication use among elderly patients attending outpatient clinics?

Study Design: Cross-sectional prescription review

Setting: Medical outpatient clinic, primary healthcare clinic, or chronic disease clinic

Why This Works: Older adults are at high risk of adverse drug events, prescription records are accessible, and tools such as Beers Criteria or STOPP/START criteria can be used to evaluate prescribing quality.

Topic 6: Drug-Drug Interactions Among Patients With Chronic Diseases

Research Question: What is the prevalence and clinical significance of potential drug-drug interactions among patients receiving treatment for chronic diseases?

Study Design: Cross-sectional prescription audit

Setting: Chronic disease clinic or primary healthcare clinic

Why This Works: Many patients receive multiple long-term medicines, interaction-checking tools can be applied, and the study can assess interaction severity, high-risk drug combinations, comorbidities, age, number of medicines, and documented clinical monitoring.

Topic 7: Analgesic Prescribing Patterns in Emergency Care

Research Question: What are the prescribing patterns of analgesics in the emergency department and are they appropriate for pain severity and diagnosis?

Study Design: Retrospective prescription audit

Setting: Emergency department or casualty unit

Why This Works: Pain is a common reason for emergency visits, prescription records can be reviewed, and the study can assess NSAID use, opioid use, paracetamol dosing, contraindications, renal disease, gastrointestinal risk, pain scoring, and documentation quality.

Topic 8: Proton Pump Inhibitor Prescribing Appropriateness

Research Question: What proportion of patients receiving proton pump inhibitors have an evidence-based indication for therapy?

Study Design: Retrospective prescription audit

Setting: Medical wards, outpatient clinics, or pharmacy records

Why This Works: PPIs are commonly overused, records can identify indication, duration, dose, co-prescription with NSAIDs or antiplatelets, gastrointestinal bleeding risk, and opportunities for deprescribing.

Topic 9: Corticosteroid Prescribing and Monitoring Practices

Research Question: How appropriately are systemic corticosteroids prescribed and monitored in patients receiving short-term or long-term therapy?

Study Design: Retrospective prescription and record audit

Setting: Medical outpatient clinic, dermatology clinic, respiratory clinic, or rheumatology clinic

Why This Works: Steroids are widely used and can cause significant adverse effects, and the study can assess indication, dose, duration, tapering, glucose monitoring, blood pressure, bone protection, infection risk, and documentation of counselling.

Topic 10: Generic Prescribing and Medicine Cost Saving

Research Question: What is the rate of generic prescribing and what potential cost savings can be achieved through improved generic medicine use?

Study Design: Retrospective prescription audit with cost analysis

Setting: Outpatient pharmacy, district hospital, or primary healthcare clinic

Why This Works: Generic prescribing improves affordability and medicine access, prescription and price data can be analysed, and the topic supports rational use of medicines and pharmacoeconomic decision-making.

HIV, Tuberculosis, Antimicrobials and Infectious Disease Pharmacology Research Topics

Topic 11: Adverse Drug Reactions to Antiretroviral Therapy

Research Question: What are the common adverse drug reactions among adults receiving antiretroviral therapy and what factors are associated with treatment modification?

Study Design: Retrospective cohort study

Setting: ART clinic or infectious disease clinic

Why This Works: ART is widely used in South Africa, patient records can provide regimen history, adverse effects, switch reasons, viral load, CD4 count, comorbidities, and outcomes, making the topic highly relevant to national HIV care.

Topic 12: ART Adherence and Viral Load Suppression

Research Question: What is the association between antiretroviral therapy adherence and viral load suppression among adults receiving ART?

Study Design: Cross-sectional or retrospective cohort study

Setting: ART clinic or primary healthcare clinic

Why This Works: Viral suppression is a key HIV treatment outcome, adherence can be assessed through pharmacy refill records or validated scales, and factors such as regimen type, missed visits, side effects, counselling, and duration on ART can be analysed.

Topic 13: Drug-Drug Interactions in HIV-TB Co-Infected Patients

Research Question: What are the common potential drug-drug interactions among patients receiving concurrent ART and anti-tuberculosis therapy?

Study Design: Retrospective prescription review

Setting: TB-HIV clinic, ART clinic, or infectious disease service

Why This Works: HIV-TB co-treatment is common and interaction-prone, the study can assess rifampicin-related interactions, dolutegravir dose adjustment, anticonvulsants, antifungals, corticosteroids, and clinical documentation of interaction management.

Topic 14: Anti-Tuberculosis Drug-Induced Liver Injury

Research Question: What is the incidence, risk factors, and clinical outcome of anti-tuberculosis drug-induced liver injury?

Study Design: Retrospective cohort study

Setting: TB clinic, infectious disease unit, or medical wards

Why This Works: Hepatotoxicity is an important complication of TB treatment, laboratory records and clinical files can identify liver enzyme elevation, symptoms, HIV status, alcohol use, viral hepatitis, treatment interruption, rechallenge, and outcomes.

Topic 15: Linezolid Toxicity in Drug-Resistant Tuberculosis

Research Question: What are the haematological and neurological adverse effects among patients receiving linezolid for drug-resistant tuberculosis?

Study Design: Retrospective cohort study

Setting: Drug-resistant TB clinic or TB referral hospital

Why This Works: Linezolid is important in DR-TB regimens but toxicity limits use, records can provide duration of therapy, haemoglobin, platelet count, neuropathy symptoms, dose modification, treatment interruption, and final treatment outcomes.

Topic 16: Antibiotic De-Escalation Practices in Hospitalised Patients

Research Question: How often are antibiotics de-escalated after culture and sensitivity results become available?

Study Design: Retrospective audit

Setting: Medical wards, surgical wards, ICU, or antimicrobial stewardship unit

Why This Works: De-escalation is a core antimicrobial stewardship practice, microbiology and prescription records can be reviewed, and outcomes include culture positivity, spectrum change, duration of therapy, documentation, mortality, and length of stay.

Topic 17: Surgical Antimicrobial Prophylaxis Compliance

Research Question: What proportion of surgical patients receive antimicrobial prophylaxis according to guideline recommendations?

Study Design: Retrospective or prospective audit

Setting: Surgical theatre, obstetric theatre, or orthopaedic theatre

Why This Works: Surgical prophylaxis is frequently misused, the study can assess antibiotic choice, timing before incision, dose, redosing, duration after surgery, allergy documentation, and surgical site infection outcomes.

Topic 18: Antifungal Prescribing Patterns in Hospitalised Patients

Research Question: What are the indications, choice, and appropriateness of systemic antifungal prescribing in hospitalised patients?

Study Design: Retrospective prescription audit

Setting: Medical wards, ICU, oncology unit, or infectious disease service

Why This Works: Antifungals are costly and require appropriate use, the study can evaluate candidiasis, cryptococcosis, prophylaxis, HIV status, neutropenia, culture confirmation, dosing, renal adjustment, and treatment duration.

Topic 19: Nephrotoxicity Associated With Aminoglycoside Use

Research Question: What is the incidence of acute kidney injury among patients treated with aminoglycosides and what factors predict nephrotoxicity?

Study Design: Retrospective cohort study

Setting: Inpatient wards, ICU, or pharmacy department

Why This Works: Aminoglycosides require careful monitoring, creatinine trends and dosing records can be reviewed, and the study can assess age, baseline renal function, dehydration, sepsis, dose, duration, concurrent nephrotoxins, and therapeutic drug monitoring.

Topic 20: Antimicrobial Stewardship Intervention and Antibiotic Consumption

Research Question: Does implementation of an antimicrobial stewardship intervention reduce antibiotic consumption or improve prescribing appropriateness?

Study Design: Before-and-after interventional audit

Setting: Hospital antimicrobial stewardship programme

Why This Works: The topic is service-relevant and publication-friendly, antibiotic consumption can be measured using defined daily doses or days of therapy, and changes in guideline compliance, broad-spectrum antibiotic use, culture testing, and cost can be evaluated.

Chronic Disease Pharmacology, Therapeutic Monitoring and Pharmacoeconomics Research Topics

Topic 21: Antihypertensive Prescribing Patterns and Blood Pressure Control

Research Question: What are the antihypertensive prescribing patterns among adults with hypertension and how do these patterns relate to blood pressure control?

Study Design: Cross-sectional prescription and clinical record review

Setting: Primary healthcare clinic or chronic disease clinic

Why This Works: Hypertension is highly prevalent, medication and blood pressure records are readily available, and the study can assess drug classes, combination therapy, guideline compliance, adherence, comorbid diabetes, renal disease, and uncontrolled hypertension.

Topic 22: Diabetes Medicine Use and Glycaemic Control

Research Question: What are the prescribing patterns of antidiabetic medicines and how are they associated with glycaemic control among adults with type 2 diabetes?

Study Design: Retrospective or cross-sectional analytical study

Setting: Primary healthcare clinic, diabetic clinic, or medical outpatient clinic

Why This Works: Diabetes management requires long-term pharmacotherapy, records can provide HbA1c, glucose values, metformin use, insulin use, sulfonylurea use, renal function, hypoglycaemia episodes, and treatment intensification patterns.

Topic 23: Statin Prescribing for Cardiovascular Risk Reduction

Research Question: How appropriately are statins prescribed for primary and secondary prevention of cardiovascular disease?

Study Design: Retrospective prescription audit

Setting: Medical outpatient clinic or chronic disease clinic

Why This Works: Statins are important for cardiovascular prevention, the study can evaluate indications, intensity, lipid monitoring, diabetes, hypertension, previous stroke or myocardial infarction, and missed opportunities for therapy.

Topic 24: Warfarin Control and Time in Therapeutic Range

Research Question: What proportion of patients receiving warfarin achieve adequate anticoagulation control and what factors are associated with poor time in therapeutic range?

Study Design: Retrospective cohort study

Setting: Anticoagulation clinic or medical outpatient clinic

Why This Works: Warfarin requires frequent monitoring, INR records are usually available, and the study can assess indication, dose changes, bleeding, thrombotic events, interacting drugs, missed visits, diet counselling, and time in therapeutic range.

Topic 25: Therapeutic Drug Monitoring of Vancomycin

Research Question: How appropriately is vancomycin therapeutic drug monitoring performed and what proportion of patients achieve target trough concentrations?

Study Design: Retrospective audit

Setting: ICU, medical wards, paediatric wards, or pharmacy department

Why This Works: Vancomycin dosing requires monitoring to improve efficacy and reduce toxicity, records can evaluate indication, renal function, dose, timing of trough sample, target attainment, nephrotoxicity, and dose adjustment.

Topic 26: Antiepileptic Drug Adherence and Seizure Control

Research Question: What factors are associated with poor adherence to antiepileptic drugs and uncontrolled seizures?

Study Design: Cross-sectional analytical study

Setting: Neurology clinic, medical outpatient clinic, or district hospital clinic

Why This Works: Epilepsy requires long-term medicine adherence, validated adherence tools and prescription records can be used, and factors such as side effects, dosing frequency, stigma, cost of transport, substance use, and clinic follow-up can be studied.

Topic 27: Pharmacoeconomic Analysis of Insulin Therapy in Type 2 Diabetes

Research Question: What is the direct medicine cost and clinical outcome profile of different insulin regimens used in adults with type 2 diabetes?

Study Design: Retrospective pharmacoeconomic analysis

Setting: Diabetic clinic or pharmacy department

Why This Works: Insulin therapy has major cost and service implications, data can include regimen type, dose, HbA1c, hypoglycaemia, clinic visits, hospital admissions, and estimated medicine cost per patient.

Topic 28: Medicine Stock-Outs and Impact on Chronic Disease Care

Research Question: What is the frequency of essential medicine stock-outs and how do they affect treatment continuity among chronic disease patients?

Study Design: Facility-based record review with patient or staff survey

Setting: Primary healthcare clinic or district pharmacy service

Why This Works: Medicine availability is essential for effective care, stock registers and patient records can be reviewed, and the study can assess antihypertensives, diabetes medicines, ART, TB drugs, antiepileptics, substitution practices, missed doses, and patient outcomes.

Topic 29: Cost Analysis of Brand Versus Generic Medicines

Research Question: What is the potential cost difference between branded and generic medicines commonly prescribed for chronic diseases?

Study Design: Pharmacoeconomic cost-minimisation study

Setting: Pharmacy department, outpatient clinic, or medicine procurement database

Why This Works: Medicine cost affects access and health system sustainability, prescription and pricing data can be analysed, and the study supports evidence-based procurement and generic substitution policies.

Topic 30: Patient Understanding of Prescribed Medicines

Research Question: What proportion of patients understand the indication, dose, timing, and side effects of their prescribed medicines?

Study Design: Cross-sectional questionnaire-based study

Setting: Outpatient pharmacy, chronic disease clinic, or primary healthcare clinic

Why This Works: Poor understanding contributes to non-adherence and adverse outcomes, interviews can assess medicine literacy, counselling quality, language barriers, number of medicines, education level, and preference for written or verbal instructions.

Getting Your HPCSA Research Protocol Generated

If you’ve selected a research topic from this list, the next step is developing a comprehensive research protocol that meets HPCSA requirements, gains supervisor approval, and successfully passes IRB review.

What a Complete Research Protocol Includes

• Title and Introduction: Clear research question and background
• Literature Review: Summary of current evidence with international journal references relevant to pharmacology, clinical pharmacology, pharmacovigilance, antimicrobial stewardship, pharmacoeconomics, and rational medicine use
• Methodology: Detailed study design, population, sampling, inclusion criteria, exclusion criteria, prescription audit methods, pharmacovigilance assessment, laboratory monitoring, data collection procedures, and outcome measures
• Statistical Analysis: Sample size calculation, descriptive analysis, comparative statistics, regression analysis, cost analysis, causality assessment, preventability assessment, or risk factor modelling where appropriate
• Ethical Considerations: IRB submission requirements, informed consent where applicable, confidentiality, anonymisation of prescription and patient data, and secure handling of pharmacy, laboratory, and clinical records
• Timeline: Gantt chart with realistic milestones for 4-year registrar training
• Budget: Resource requirements and cost breakdown
• References: Vancouver or APA style citations

Journals for HPCSA Pharmacology Research

South African Journals

• South African Medical Journal (SAMJ) – Accepts pharmacology, medication safety, antimicrobial stewardship, HIV, TB, and health systems research
• Southern African Journal of Infectious Diseases – Suitable for antimicrobial use, stewardship, HIV pharmacotherapy, TB treatment, and infectious disease pharmacology
• African Journal of Primary Health Care & Family Medicine – Suitable for rational prescribing, chronic disease pharmacotherapy, adherence, and primary care medicine-use research

International Journals

• British Journal of Clinical Pharmacology – Clinical pharmacology, drug safety, pharmacokinetics, and therapeutics research
• Clinical Pharmacology & Therapeutics – High-impact clinical pharmacology and translational therapeutics journal
• Drug Safety – Pharmacovigilance, adverse drug reactions, and medication safety research
• BMC Pharmacology and Toxicology – Broad pharmacology, toxicology, and drug safety research
• Journal of Antimicrobial Chemotherapy – Antimicrobial pharmacology, resistance, and stewardship research
• Pharmacoepidemiology and Drug Safety – Medicine-use studies, adverse events, and pharmacoepidemiology research
• International Journal of Clinical Pharmacy – Prescribing quality, medication safety, adherence, and clinical pharmacy research

HPCSA Pharmacology Registrar Research Requirements

All HPCSA pharmacology registrars must complete a research project during their 4-year specialist training programme. The research protocol should be developed early in training, approved by a supervisor, submitted for institutional ethics review before data collection, and aligned with clinically relevant pharmacology, medicine safety, and rational prescribing priorities in South Africa.

Given South Africa’s pharmacology priorities – including antimicrobial resistance, HIV treatment, tuberculosis pharmacotherapy, adverse drug reaction monitoring, rational prescribing, medication errors, drug interactions, chronic disease medicines, medicine access, pharmacoeconomics, and therapeutic drug monitoring – pharmacology research topics should be practical, ethically sound, and relevant to real-world clinical and public health medicine use while maintaining strong academic and methodological standards.